Our regenerative approach uses PRP therapy to reduce joint pain and enhance tissue repair
(2008) Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system
Neurotrophic and anti-inflammatory effects (days to weeks) Semax elevates BDNF within hours, but the downstream effects of that elevation, including new synaptic connections, improved neurotransmitter signaling, and reduced inflammatory gene expression, unfold over days and weeks
Ph & Charge Behaviour Peptide solubility is strongly influenced by pH
While patient stories are compelling (such as recovery from stubborn tendonitis in weeks) its important to remember that BPC-157 is still under study, and to always consult a qualified clinician before use